S.Amdt. 3333Senate114th Congress (2015-2017)
S.Amdt. 3333
Sponsored by
Sen. Richard Blumenthal (D-CT)
Submitted February 29, 2016
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
February 29, 2016
View full timeline
Floor
Senate amendment submitted
February 29, 2016
Floor
Senate amendment submitted
February 29, 2016
Text
Submitted
SA 3333. Mr. BLUMENTHAL submitted an amendment intended to be proposed by him to the bill S. 524, to authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse and heroin use; which was ordered to lie on the table; as follows: At the end, add the following: SEC. 705. REMS FOR IMMEDIATE RELEASE OPIOID ANALGESICS. Not later than 120 days after the date of enactment of this Act, the Secretary of Health and Human Services shall require a risk evaluation and mitigation strategy under section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1) to be submitted for drugs that are immediate release opioid analgesics, including for such drugs for which there is an approved covered application (as defined in such section) and for such drugs for which a covered application has been submitted but not yet approved. ______